DAWN (Day One Biopharmaceuticals) OCF Margin %: -26.34% (As of Dec. 2025)

What is Day One Biopharmaceuticals OCF Margin %?

Day One Biopharmaceuticals DAWN 12 OCF Margin % is -26.34% as of Dec. 2025. GuruFocus rates DAWN with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Day One Biopharmaceuticals ranks worse than 50.16% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Day One Biopharmaceuticals's Cash Flow from Operations for the three months ended in Dec. 2025 was $-14.1 Mil. Day One Biopharmaceuticals's Revenue for the three months ended in Dec. 2025 was $53.7 Mil. Therefore, Day One Biopharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2025 was -26.34%.

As of today, Day One Biopharmaceuticals's current OCF Yield % is -4.66%.

The historical rank and industry rank for Day One Biopharmaceuticals's OCF Margin % or its related term are showing as below:

DAWN' s OCF Margin % Range Over the Past 10 Years
Min: -65.59 Med: -62.58 Max: -59.56
Current: -65.59

During the past 7 years, the highest OCF Margin % of Day One Biopharmaceuticals was -59.56%. The lowest was -65.59%. And the median was -62.58%.

DAWN's OCF Margin % is ranked worse than
50.16% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs DAWN: -65.59

Day One Biopharmaceuticals OCF Margin % Related Terms

Day One Biopharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Day One Biopharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Day One Biopharmaceuticals OCF Margin % Chart

Day One Biopharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

-59.56

-65.59

Day One Biopharmaceuticals Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
OCF Margin %	Get a 7-Day Free Trial															-102.74	-191.79	-73.16	-14.59	-26.34

DAWN vs TYRA, DFTX, MLYS: OCF Margin % Comparison

For the Biotechnology subindustry, Day One Biopharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Day One Biopharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Day One Biopharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Day One Biopharmaceuticals's OCF Margin % falls into.

Save Embed

12GF Score

Day One Biopharmaceuticals Inc DAWN

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Day One Biopharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Day One Biopharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-103.757	/	158.182
	=	-65.59 %

Day One Biopharmaceuticals's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-14.149	/	53.718
	=	-26.34 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -26.34% mean?

Day One Biopharmaceuticals (DAWN) has a OCF Margin % of -26.34% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Day One Biopharmaceuticals and its competitors. According to the industry distribution chart, Day One Biopharmaceuticals ranks #481 out of 959 companies in the Biotechnology industry, placing it in the top 50.2%.

Is Day One Biopharmaceuticals' OCF Margin % too high?

Day One Biopharmaceuticals' current OCF Margin % is -26.34%. Based on the distribution chart, Day One Biopharmaceuticals ranks #481 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Day One Biopharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Day One Biopharmaceuticals' OCF Margin % compare to TYRA and DFTX?

According to the Biotechnology industry distribution chart, Day One Biopharmaceuticals ranks #481 out of 959 companies for OCF Margin %. This places Day One Biopharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Day One Biopharmaceuticals and its competitors. Day One Biopharmaceuticals's current OCF Margin % is -26.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Day One Biopharmaceuticals stock overvalued right now?

Day One Biopharmaceuticals (DAWN) has a current OCF Margin % of -26.34%. The current OCF Margin % is -26.34%. Day One Biopharmaceuticals' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Day One Biopharmaceuticals (DAWN), the current OCF Margin % is -26.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Day One Biopharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies TYRA DFTX MLYS ADPT SRPT ZYME RARE AUPH OCUL TRVI VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ASX:CSL ALNY ONC XKRX:068270 INSM

Address 1800 Sierra Point Parkway, Suite 200, Brisbane, CA, USA, 94005

Website https://www.dayonebio.com

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

12GF Score

Get the complete analysis for DAWN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.53

Price

View DAWN Analysis

See OCF Margin % data for all stocks →